Key and Abbreviations:

A refers to the page number, followed by the abstract number.

30 day major adverse cardiovascular events A50 66

3D feature tracking A82 111

4D Flow A83 112

A and E A3 5

ABLATIONS A37 47

ablation A25 32

ACHD A62 85

ACS A50, A52 67, 69

Acute Coronary Syndromes A45 59

acute coronary syndrome A42, A43, A43, A44, A48, A49, A50, A51, A52, A53 54, 55, 56, 58, 64, 65, 66, 68, 70, 71

ADAMTS A111 A152

adaptive immunity A124 180

Advanced Glycated Endproducts A126 183

Advanced Heart Failure A16 20

affimer A116 A163

Agatston score A88 117

ageing A111, A131, A150 153, A194, B

Alignment A126 185

Alternative translation A141 214

Amphiphysin II A120 171

amyloid A38 48

Anaesthetic A69 95

aneurysm A111 A152

Angiogenesis A107, A110, A121, A127 144, A150, 173, 186

Angiography A47, A64 62, 89

Angioplasty A17 22

Angiopoietin 1 A131 192

Angiotensin Receptor-Neprilysin Inhibitor A1 2

animal models A108 147

animal model A143 220

anti-oxidised LDL antibodies A112 A155

anti-platelets A74 99

antibiotics A100 134

anticoagulation A37, A57 46, 76

antigen presentation A124 180

Antioxidants A143 219

antiplatelet therapies A108 147

aorta A102 138

Aortic stenosis A97, A97, A99 128, 129, 132

aortic valve repair A102 138

ApoE deficiency A146 226

Apoptosis A120 172

Appropriate Use Criteria A89 118

Arrhythmia A142, A143, A29 216, 220, 36

Arterio-venous iliac fistula A64 88

aspirin A74 99

atherosclerosis A117, A119, A124, A136, A137 165, 169, 180, 201, 203

Athlete’s heart A91 121

atrial arrhythmias A58 80

Atrial arrhythmia A26 33

Atrial fibrillation A112, A149, A27, A31, A33, A33, A35, A36, A37 A154, 233, 34, 39, 41, 42, 44, 45, 46

atrial myocyte A109 149

ATRIAL A143 221

Atrioventricular node ablation A31 40

audit A74 100

Aurintricarboxylic acid A107 144

auscultation A101 136

Autophagy A142 217

bacteraemia A100 135

Beta Adrenergic Signalling A104 139

beta-amyloid A140 213

Beta-catenin A120 172

Biological Tricuspid Valve Replacement A62 84

biomarker A119 169

Bioresorbable polymer scaffold A121 174

BK channel A130 190

Blood pressure, A33 A41

blood pressure A63 86

bmal1 circadian rhythm A109 149

BMP signalling A136 202

BNP A96 127

CABG A47, A53 62, 72

CAC A88 117

Calcification A139, A144 210, 223

calcium influx A107 A143

calcium A113, A124 156, 179

carbon monoxide A130 190

Cardiac axis A4 8

cardiac fibrosis A130 191

cardiac hypertrophy A142, A142, A146 217, 218, 228

Cardiac injury A107 A143

Cardiac MRI A80, A82, A39 109, 111, 50

cardiac outpatient A74 100

Cardiac Physiology A120 171

cardiac remodelling A152 E

Cardiac resynchonisation therapy A4 7

Cardiac Resynchronisation Therapy A14, A15, A4, A5 18, 19, 8, 9

Cardiac Surgery A149 233

Cardiac A113, A139 A158, 209

cardio-oncology A146 228

Cardiogoniometry A76, A4 103, 8

CARDIOMYOCYTE A143 221

Cardiomyopathy A7, A11, A38 12, 15, 48

Cardioprotection A119, A131 168, 193

Cardiopulmonary exercise testing A7, A99, A64 11, 132, 88

Cardiopulmonary exercise test A99 133

Cardiovascular Risk Factors A68 93

carotid intima-media thickness A43 56

Catheter ablation A27 34

caveolae A140 212

cavotricuspid line isthmus A58 78

CcTGA A59 81

Cell Signalling A126 184

cerebral anatomy A64 87

Chest pain A50, A66, A73 67, 90, 98

chronic kidney disease A7, A141 11, 215

Chronotopic incompetence A12 16

clinical outcomes A22 26

Clinical recommendations A76 102

clopidogrel A52 70

Clozapine A7 12

CMR A85 113

cognitive impairment A50 66

Collateral Circulation A19, A20 23, 24

Complications A55, A62 74, 85

Complication A23 28

Congenital heart disease A115, A54, A56, A58, A58, A58, A62 162, 73, 75, 78, 79, 80, 84

Congestive Heart Failure A8 13

contractile reserve A94 124

copy number variants A115 162

Coronary Angiography A23 28

Coronary Artery Bypass Graft Surgery A23 28

coronary artery diseaes A66 91

Coronary artery disease A76, A77, A79, A80, A108, A64, A66 103, 104, 107, 108, 145, 89, 90

Coronary Flow Reserve A87 115

coronary patients A63 86

Coronary Physiology A16 21

CORONARY PRESSURE A19, A20 23, 24

creatine kinase A144 222

CRISPR/CAS9 A133 195

CRT A59 81

CTO A19, A20 23, 24

Cyanotic Cardiac Conditions A55 74

cyclooxygenase-1 A108 147

dabigatran A36 45

Damage A139 209

defibrillation A109, A139 148, 209

device therapy A38 48

Devices A14, A15 18, 19

Diabetes mellitus A149 232

Diabetes A127, A135, A140, A143 186, 200, 213, 219

Diagnostic testing A89 118

Diamond Forrester A66 91

Dilated cardiomyopathy A95 125

DNA binding A133 197

DNA damage A145 225

Drp1 A147 229

ECC A118 166

ECG and Echo A98 130

ECG gated CT scans A88 117

ECG strain patten A97 128

ECG A35 44

echocardiography A90, A93, A102, A11 120, 123, 137, 15

Echo A91 122

ECM A111 A152

effective biventricular pacing A5 9

eisenmenger A54 73

Electronic health record A74 100

End of Life A41 53

Endocarditis A100, A100 134, 135

Endocytosis A110 A150

Endothelial Cells A133 196

Endothelial cell A121 173

Endothelial dysfunction A140, A149, A44 213, 232, 57

endothelial A115 161

entrainment A58 78

Eosinophils A152 E

epicardium A140 211

epidemiology A48 64

Erythrocytosis A55 74

ESC Guidelines A76 102

Ethnicity A99 133

Evidence based medicine A76 102

Exercise Electrocardiography A80 108

Exercise Stress Echocardiography A78 106

Exercise A96, A12 127, 16

exome sequencing A115 162

Extracellular matrix A137 203

Extracellular vesicles A150 A

Extraction technique A28 35

extreme anthropometry A91 121

Fabry Disease A38 49

Failure A23 29

FERROPORTIN A137 204

Fetal growth A108 146

Fetuin-A A119 170

FGF-2 A139 210

fibrosis A97, A123, A138 129, 178, 206

Fingolimod A119, A149 168, 233

FLUROSCOPIC A30 38

Fontan A59, A60 81, 82

Fractional Flow Reserve A76, A87 103, 115

frailty A42 54

Frequency Adaptation A128 188

Functional Capacity A60 82

fusion beats A5 9

gender A97, A48 129, 63

GENE EDITING A133 195

Gene expression profiling A97 128

Genetics A95 125

Genotype A95 126

Gi A135 199

glucose control A63 86

Glycolysis A144 223

glypican A137 205

Graft notes A47 62

graphene A108 145

guidance A100 134

GWAS A106 141

Haemoglobin A108 146

Haem A130 190

HDAC7 A141 214

Health economics A27 34

heart failure with reduced ejection fraction A1 1

Heart Failure A8, A105, A11, A115, A14, A134, A15, A138, A31, A2, A3, A3 13, 140, 15, 160, 18, 198, 19, 206, 40, 4, 5, 6

Heart Rhythm Control A142 216

heart transplantation A14 17

Heart Transplant A10 14

Heart A141 215

helix-turn-helix A133 A197

Hepcidin A137 204

Heterogeneity A138, A140 207, 211

HFpEF A12 16

HFrEF A1, A2 2, 3

high CVD population A63 86

High-sensitivity troponin A44 58

Hippo A122 176

Holter monitoring A35 44

Hospital Episode Statistics A2 4

hsTnI A52 69

Hypertension A75, A106, A115, A125, A130, A145, A64, A64 101, 141, 160, 181, 191, 224, 87, 88

Hypertrophic cardiomyopathy A95, A96, A98, A99 126, 127, 131, 133

Hypertrophy A126 184

Hypoplastic left heart A60 83

ibrutinib A115 161

ICD A98, A2, A41, A57 131, 3, 53, 77

IGF binding proteins A121 173

IHD A14 17

Imaging biomarker A81 110

immune complexes A119 169

immunoglobulins A112 A155

Implantable cardiac defibrillator A4 7

Implantable Cardioverter-Defibrillators A40 51

IMR A85 113

Indications A41 52

Inflammation A113, A146, A151 A157, 227, C

Interleukin-1 A131 A192

Interleukin-6 A146 227

Intra-aortic balloon pump A16 21

in vivo cell tracking A148 A230

Iron deficiency A2 4

IRON A137 204

Ischaemia-reperfusion A147 229

ischaemia/reperfusion A144 222

Ischaemic heart disease A78 106

Ischaemic preconditioning A131 193

Ischemia-reperfusion injury A119 168

JAK/STAT A140 212

Kidney transplantation A5 A10

Kinetic Energy A83 112

knockout A123 177

Late gadolinium enhancement A81 110

late outgrowth endothelial cells A148 230

learning curve A102 138

left atrial appendage A24 30

left ventricular morphology A91 121

Left Ventricular Non Compaction A56 75

Leptin A118 167

Lipid handling A136 201

lipids A63 86

Lipid A106, A113 141, A157

Lipoprotein apheresis A69 94

Lipoprotein(a) A69 94

LONG-TERM OUTCOMES A30, A73 37, 98

Long-term outcones A58 79

Long-term A23 29

Low Birth Weight A75 101

low-dose dobutamine stress echocardiography A94 124

low-flow low-gradient aortic stenosis A94 124

LOX-1 A116 A163

LV ENDOCARDIAL PACING A30 37

LV hypertrophy A98 130

LV mass A98 131

LV structure and function A5 A10

LVAD A16 20

Macrophage polarisation A136 201

Macrophage A113, A141 A157, 215

magnetic resonance imaging A151 C

magnetic A86 114

major adverse cardiovascular events A43, A44 55, 57

malnutrition A3 6

Manganese A113 A158

MAP1S A142 217

Mapping A26 33

Marital Status A68 93

Mechanical performance A121 174

Meta-analysis A40 51

Metabolism A135 200

micro-RNA A130 191

Microcirculation A75 101

MICRORNA A133, A135 195, 199

Microvascular ischaemia A85 113

MINAP Database A45 59

MINS A71 97

miR-26B A133 196

mitochondria A131, A134, A138, A143, A150 A194, 198, 208, 219, B

mitraclip A24 30

Mitral regurgitation A81, A102 110, 137

Mitral valve repair A102 137

Molecular pathway A98 130

monitoring A33 42

Monocyte A150 A

Mortality A41, A51, A68 52, 68, 93

mouse A123, A123 177, 178

MRA A2 3

MRI A113, A123, A64 A158, 178, 87

Multidisciplinary A69 95

Multiplate A53 72

murmur A101 136

myocardial contrast echocardiography A79 107

myocardial infarction A138, A146, A151, A152 208, 227, C, E

NADPH oxidase 2 A146 226

NADPH oxidases A112 A154

NADPH oxidase A125, A142 181, 218

Neointima A118 167

NICE guidance A77 104

Nitric oxide synthase A120 172

Nitric oxide A108, A135 146, 200

NLS A133 197

NOACS A37 46

NOAC A37 47

non-ischaemic heart failure A14 17

Novel Therapeutics A126 183

Nox2 A111 153

Nox5 A111 151

oLDL A116 A163

Optical Mapping A128 188

Osteoprotegerin A125 182

Out of Hospital Cardiac Arrest A17 22

oxidative DNA damage A117 165

oxidative injury A144 222

Oxidative Stress A111, A111, A125, A142, A145, A149 151, 153, 181, 218, 224, 232

Oxidised LDL A69 94

P2Y12 Inhibitors A128 187

P2Y12-inhibitors A22 26

PACEMAKER A30, A4 38, 7

paediatric A109 148

PAH A113, A136 156, 202

parathyroid hormone A43, A43 55, 56

PASMC A136 202

patent foramen ovale A24 30

PCI A21 25

Percutaneous coronary intervention A16, A17 21, 22

perfusion A86 114

Pericytes A127 186

Permanent pacemaker A31 40

persistent Na channels A109 149

Pharmacology A104 139

phenotype A123 177

Phosphoinositide 3-kinase A131 193

Phosphorylation carrier A141 214

PICs A138 206

PIV A126 185

Platelets A128 187

platelet A115, A129 161, 189

PMCA1 A105 140

PMCA4 A107 144

PMCA A113, A142 156, 216

Poincare A143 220

pore-forming toxins A107 A143

post-myocardial infarction remodelling A105 140

pre-clinical imaging A148 230

Pre-operative A71 97

Pre-test likelihood A77, A64 104, 89

Pregnancy A129, A56, A57, A57 189, 75, 76, 77

Preoperative A69 95

Pressure wire study A80 109

Prevention A67 92

Primary PCI A22 27

Primary percutaneous coronary intervention A22 26

primary prevention A74 99

Pro Survival A133 196

Progenitor Cells A118 167

Prognosis A10 14

Prognostication A80 109

Proliferation A122 176

Prosthetic valves A57 76

Proteomics and biomarkers A137 203

Psychosocial outcomes A70 96

pulmonary arterial hypertension A54 73

pulmonary hypertension A89, A90 119, 120

QOF A67 92

Quality Improvement A8, A41 13, 53

quality of life A42, A70 54, 96

Quality A49 65

Questionnaires A57 77

reactive oxygen species A138 208

Readmissions A3 5

Readmission A21 25

Refractory Angina A70 96

Registry A28 35

Renal dysfunction A16 20

reproducibility A93 123

resonance A86 114

retrograde aortic access A58 80

revascularisation A48 64

right heart catheter A90 120

risk score A66 91

risk stratification A25, A44 32, 58

rivaroxaban A36 45

RNA sequencing A140 211

RNA-Seq A138 207

Rotational atherectomy A22 27

ryanodine receptor A112, A148 A154, 231

S-nitrosylation A134 198

sacubitril/valsartan A1, A1 1, 2

SBF-SEM A118 166

Screening service A31 39

SCREENING A30, A3, A66 38, 6, 90

Secondary prevention A53 71

senescence associated secretory phenotype A145 225

sepsis A100 135

septation A137 205

SERCA A122 175

Serotonin A122 176

service A78 106

signalling A115, A146 160, 228

Sildenafil A124 179

single photon emission computed tomography A79 107

Single-coil leads A40 51

skeletal muscle A146 226

Sleep disordered breathing A31 39

Smoker’s paradox A46 61

Smoking A46, A48 61, 63

smooth muscle A117 165

SOCS3 A140 212

SODIUM A143 221

Software A128 188

Somatostatin receptor-2; Atherosclerosis; Inflammation A151 D

SPECT A89 119

ST elevation myocardial infarction A22 27

ST2 A10 14

Stable angina A73 98

Statin A67 92

STEMI A46, A48 61, 63

stents A108 145

STORM A148 231

Strain imaging A82 111

Strain A60 83

Stress Echocardiography A80, A87, A99 108, 115, 132

stroke A33 42

Subclinical heart disease A7 11

Subcutaneous ICD A41 52

sudden cardiac arrest A109 148

Sudden cardiac death A38, A39 49, 50

SUMOylation A147 229

Super resolution A148 231

Surgery A62 85

SVT A58 79

Syncope A29 36

Syndecan-1 A125 182

Syndecan-4 A139 210

Systemic right ventricle A60 83

Tachycardia A7 12

Takotsubo A135 199

target dose A1 1

TAVI A91, A126, A23, A25 122, 185, 29, 31

TBQ A122 175

Technology A26 33

Testing and modelling A121 174

tetralogy A137 205

Thirty day A21 25

Thrombosis A128, A129 187, 189

ticagrelor A52, A53 70, 72

Tie2 A110, A131 A150, 192

Tissue Doppler imaging A95 126

Titin A95 125

tloc A29 36

Toll-like receptor 4 A119 170

Transapical A25 31

TRANSEPTAL PUNCTURE A30 37

Transfemoral A25 31

Transthoracic Echocardiography A89 118

Transvenous leads A28 35

Transverse Tubules A120 171

Transverse-axial tubule A118 166

Troponin A49, A50, A52, A71 65, 67, 69, 97

Two Pore Channels A104 139

Type 2 Infarctions A45 59

Up-titration A53 71

uraemic cardiomyopathy A5 A10

Urotensin II A126 184

Valve performance A62 84

Valvular Degeneration A91 122

valvular heart disease A93, A101 123, 136

Vascular Calcification A126, A145 183, 225

Vascular Dysfunction A111, A119, A125 151, 170, 182

vascular A131, A150 A194, B

VEGF inhibition A145 224

ventilation/perfusion A89 119

ventricular arrhythmia A25, A39 32, 50

Ventricular arrythmia A38 49

Ventricular function A60 82

ventricular myocytes A122 175

Ventricular Thrombus A83 112

vitamin D A44 57

VSMC A138, A144 207, 223

Vulnerable plaque A112 A155

WARFARIN A37 47

Wave A124 179